Diego Signorelli

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

Giuseppe Lo Russo, Massimo Moro, Michele Sommariva et al. · Clinical Cancer Research · 2018 · 400 citations · Full text

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

Giovanni Fucà, Giulia Galli, M. Poggi et al. · ESMO Open · 2019 · 203 citations · Full text

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Lorenza Landi, Federica D’Incà, Alain Gelibter et al. · Journal for ImmunoTherapy of Cancer · 2019 · 164 citations · Full text

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

Alessio Cortellini, Massimo Di Maïo, Olga Nigro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 132 citations · Full text

Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation

James P. Robinson, M W VanBrocklin, Adam R. Guilbeault et al. · Oncogene · 2009 · 95 citations · Full text

Knockout Mouse, Neuro-oncology, Signaling Pathway +11